Similar articles

• Effect of hypocaloric diet plus sibutramine treatment on hormonal and metabolic features in overweight and obese women with polycystic ovary syndrome: a randomized, 24-week study.

  Florakis D, Diamanti-Kandarakis E, Katsikis I, Nassis GP, Karkanaki A, Georgopoulos N, Panidis D. Florakis D, et al. Int J Obes (Lond). 2008 Apr;32(4):692-9. doi: 10.1038/sj.ijo.0803777. Epub 2007 Dec 11. Int J Obes (Lond). 2008. PMID: 18071341 Clinical Trial.
• Effect of sibutramine on weight reduction in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial.

  Lindholm Å, Bixo M, Björn I, Wölner-Hanssen P, Eliasson M, Larsson A, Johnson O, Poromaa IS. Lindholm Å, et al. Fertil Steril. 2008 May;89(5):1221-1228. doi: 10.1016/j.fertnstert.2007.05.002. Epub 2007 Jul 2. Fertil Steril. 2008. PMID: 17603048 Clinical Trial.
• Weight loss and quality of life improvement in obese subjects treated with sibutramine: a double-blind randomized multicenter study.

  Di Francesco V, Sacco T, Zamboni M, Bissoli L, Zoico E, Mazzali G, Minniti A, Salanitri T, Cancelli F, Bosello O. Di Francesco V, et al. Ann Nutr Metab. 2007;51(1):75-81. doi: 10.1159/000100824. Epub 2007 Mar 15. Ann Nutr Metab. 2007. PMID: 17356258 Clinical Trial.
• Does drug therapy of obesity have a future?

  Trakas K, Leiter L, Shear NH. Trakas K, et al. Can J Clin Pharmacol. 2000 Autumn;7(3):133-4. Can J Clin Pharmacol. 2000. PMID: 11044757 Review. No abstract available.
• Sibutramine: its mode of action and efficacy.

  Finer N. Finer N. Int J Obes Relat Metab Disord. 2002 Dec;26 Suppl 4:S29-33. doi: 10.1038/sj.ijo.0802216. Int J Obes Relat Metab Disord. 2002. PMID: 12457297 Review.